Orbimed Advisors LLC Zai Lab LTD Transaction History

Orbimed Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $12.4 Million - $21 Million	-254,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $10.2 Million - $16.4 Million	-260,000 Reduced 50.58%	254,000 $13.1 Million
Q3 2019 Nov 14, 2019	SELL	$30.47 - $37.65 $20 Million - $24.7 Million	-655,000 Reduced 56.03%	514,000 $16.6 Million
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $5.98 Million - $8.31 Million	-232,318 Reduced 16.58%	1,169,000 $40.8 Million
Q1 2019 May 15, 2019	SELL	$21.71 - $31.54 $7.65 Million - $11.1 Million	-352,220 Reduced 20.09%	1,401,318 $41.4 Million
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $2.54 Million - $3.61 Million	142,538 Added 8.85%	1,753,538 $34.2 Million
Q2 2018 Aug 14, 2018	BUY	$18.0 - $25.01 $17.2 Million - $23.8 Million	952,840 Added 144.77%	1,611,000 $37.5 Million
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $17.8 Million - $20.5 Million	658,160	658,160 $17.8 Million

125

49.6M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.